Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial)
- To assess the effect of lifestyle factors (e.g., smoking, dietary habits, fluid intake,
or environmental exposures) on the recurrence and progression of bladder cancer.
- To assess the impact of selenium and/or vitamin E on the progression and recurrence of
- To study health-related quality of life and its association with recurrence and
progression of bladder cancer.
- To establish a bladder cancer tissue bank that will comprise blood, urine, and bladder
- To study the predictive effect of molecular markers on the recurrence and progression
of bladder cancer.
OUTLINE: This is a multicenter study.
The study will be based on a cohort of patients with newly detected bladder cancer in all 16
urological centres within the West Midlands, commencing in late 2005 for a period of 5
years. This research project consists of 5 individual studies: CRUK-BCPP-2005-01-COHORT,
CRUK-BCPP-2005-01-MARKERS, CRUK-BCPP-2005-01-QOL, CRUK-BCPP-2005-01-TISSUE-BANK, and
CRUK-BCPP-2005-01-TREATMENT. Patients may participate in all or only some of these
Peer Reviewed and Funded or Endorsed by Cancer Research UK.
Primary Purpose: Prevention
K. K. Cheng, MD
University Hospital Birmingham